true
Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Modal Close Icon
Contact us

For sales inquiries, technical support and customer support complete the following form:

Capability:

Product Line:

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representative will get in touch with you shortly.
Ordering
Phone Icon
1.714.283.2228
5 a.m. to 4 p.m. PT
Fax Icon
1.714.283.8424
oem@carefusion.com
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Fax Icon
1.800.847.2220

PowerFlow™ Implantable Apheresis IV Port

Designed for long device life, maximum flow, and patient comfort.

 

Contact Us
aitzmsznt1p59v6b6ifycjqqpx5vr3gu.jpg
Loading

Overview

PowerFlow™ Implantable Apheresis IV Port

  • Robust titanium funnel
  • Soft and lightweight silicone body
  • 9.6 F ChronoFlex® Catheter
  • IV access
  • Unique valve technology
  • Needle stop
  • High-flow, Power-injectable1
true
Features and Benefits

Optimized for Long Device Life

Bench tested up to 1,000 accesses2

 

Engineered for Maximum Flow

Large inner diameter polyurethane port catheter

 

Engineered for Patient Comfort

Totally Implantable to help address patient lifestyle

 

Bench Tested for High Flow Performance

Unique design and access delivers flow rates up to 150mL/min3 at low pressure

 

Designed for Easy Access

Access is performed at a shallow angle by percutaneous insertion of an over-the-needle soft peripheral intravenous catheter

 

 

Related Videos

The PowerFlow™ Implantable Apheresis IV Port is a high-flow, power-injectable port designed and indicated specifically for therapeutic apheresis. The PowerFlow™ Implantable Apheresis IV Port is designed for long device life, maximum flow, and patient comfort.

 

Reference

1. Power injectable up to 5mL/s @ 300 psi

2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.

3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.

true

BD-23557

Products & Accessories
Sort by:
Reference

1. Power injectable up to 5mL/s @ 300 psi

2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.

3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.

true

BD-23557

EIFUs
Resources
Reference

1. Power injectable up to 5mL/s @ 300 psi

2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.

3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.

true

BD-23557